Compare $BBNX vs $SIBN | Chartloom

Compare

$BBNX vs $SIBN

Beta Bionics Inc · SI-BONE Inc

BBNX

Beta Bionics Inc

SIBN

SI-BONE Inc

Compare $BBNX vs $SIBN

Comparing Beta Bionics Inc and SI-BONE Inc

BBNXBeta Bionics Inc

SIBNSI-BONE Inc

BBNXBeta Bionics Inc

Market cap

$793M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.37x

Rev growth (TTM)

94.1%

YTD performance

-39.7%

52W performance

-20.3%

FCF yield

-7.7%

SIBNSI-BONE Inc

Market cap

$859M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.36x

Rev growth (TTM)

15.3%

YTD performance

-2.1%

52W performance

27.4%

FCF yield

-0.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BBNX

SIBN

Detailed metrics comparison

BBNX

Beta Bionics Inc

SIBN

SI-BONE Inc

Market Cap

BBNX$793M

SIBN$859M

Enterprise Value

BBNX$749M

SIBN$862M

Price

BBNX$17.63

SIBN$19.37

P/E Ratio

BBNXN/A

SIBNN/A

P/S Ratio

BBNX6.66x

SIBN4.02x

EV/Sales

BBNX6.29x

SIBN4.03x

EV/EBITDA

BBNX0.00x

SIBN0.00x

P/B Ratio

BBNX3.99x

SIBN4.44x

P/FCF Ratio

BBNXN/A

SIBNN/A

EV/FCF

BBNX-12.19x

SIBN-196.39x

PEG Ratio

BBNXN/A

SIBNN/A

Forward P/E (NTM)

BBNXN/A

SIBNN/A

Forward P/S (NTM)

BBNX5.37x

SIBN3.36x

Revenue (TTM)

BBNX$119M

SIBN$214M

Revenue Growth (YoY)

BBNX94.1%

SIBN15.3%

Forward Rev Growth

BBNX34.2%

SIBN15.7%

Gross Margin (TTM)

BBNX58.3%

SIBN79.5%

Operating Margin (TTM)

BBNX0.0%

SIBN0.0%

EBITDA Margin (TTM)

BBNX-67.9%

SIBN-5.3%

Net Margin (TTM)

BBNX-61.3%

SIBN-6.9%

FCF Margin (TTM)

BBNX-51.6%

SIBN-2.1%

Net Income (TTM)

BBNX$-73M

SIBN$-15M

FCF (TTM)

BBNX$-61M

SIBN$-4M

EPS (TTM)

BBNX-$1.64

SIBN-$0.33

ROE (TTM)

BBNX-2630.0%

SIBN-823.0%

ROA (TTM)

BBNX-2325.0%

SIBN-607.0%

ROIC (TTM)

BBNX-2630.0%

SIBN-686.0%

Cash

BBNX$44M

SIBN$33M

Debt

BBNX$0

SIBN$36M

Net Cash/Debt

BBNX$44M

SIBN$-3M

Current Ratio (TTM)

BBNX8.88x

SIBN9.15x

Quick Ratio (TTM)

BBNX7.72x

SIBN7.37x

Debt/Equity (TTM)

BBNX0.00x

SIBN0.20x

Debt/Assets (TTM)

BBNX0.0%

SIBN0.0%

Interest Coverage (TTM)

BBNXN/A

SIBNN/A

Net Debt/EBITDA (TTM)

BBNX0.00x

SIBN0.00x

Beta

BBNX0.92

SIBN0.65

52W Performance

BBNX-20.3%

SIBN27.4%

YTD Performance

BBNX-39.7%

SIBN-2.1%

% from 52W High

BBNX-46.1%

SIBN-11.5%

% from 52W Low

BBNX100.3%

SIBN68.7%

Asset Turnover (TTM)

BBNX0.38x

SIBN0.89x

FCF Yield (TTM)

BBNX-7.7%

SIBN-0.5%

Earnings Yield (TTM)

BBNX-9.2%

SIBN-1.7%

Dividend Yield (TTM)

BBNXN/A

SIBNN/A

Rule of 40

BBNX42.5

SIBN13.2

EV/GP/RG

BBNX0.34

SIBN0.22

Ticker research

View BBNX research View SIBN research

Metric	BBNX Beta Bionics Inc	SIBN SI-BONE Inc
Market & Valuation
Market Cap	$793M	$859M
Enterprise Value	$749M	$862M
Price	$17.63	$19.37
P/E Ratio	N/A	N/A
P/S Ratio	6.66x	4.02x
EV/Sales	6.29x	4.03x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.99x	4.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-12.19x	-196.39x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.37x	3.36x
Revenue & Growth
Revenue (TTM)	$119M	$214M
Revenue Growth (YoY)	94.1%	15.3%
Forward Rev Growth	34.2%	15.7%
Profitability
Gross Margin (TTM)	58.3%	79.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-67.9%	-5.3%
Net Margin (TTM)	-61.3%	-6.9%
FCF Margin (TTM)	-51.6%	-2.1%
Net Income (TTM)	$-73M	$-15M
FCF (TTM)	$-61M	$-4M
EPS (TTM)	-$1.64	-$0.33
ROE (TTM)	-2630.0%	-823.0%
ROA (TTM)	-2325.0%	-607.0%
ROIC (TTM)	-2630.0%	-686.0%
Financial Health
Cash	$44M	$33M
Debt	$0	$36M
Net Cash/Debt	$44M	$-3M
Current Ratio (TTM)	8.88x	9.15x
Quick Ratio (TTM)	7.72x	7.37x
Debt/Equity (TTM)	0.00x	0.20x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.92	0.65
52W Performance	-20.3%	27.4%
YTD Performance	-39.7%	-2.1%
% from 52W High	-46.1%	-11.5%
% from 52W Low	100.3%	68.7%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	0.89x
FCF Yield (TTM)	-7.7%	-0.5%
Earnings Yield (TTM)	-9.2%	-1.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	42.5	13.2
EV/GP/RG	0.34	0.22
Ticker research	View BBNX research	View SIBN research

Valuation

P/S Ratio

SIBN

4.02x

BBNX

6.66x

EV/FCF

SIBN

-196.39x

BBNX

-12.19x

Growth & revenue

Revenue Growth TTM

BBNX

94.1%

SIBN

15.3%

Forward Revenue Growth

BBNX

34.2%

SIBN

15.7%

Profitability & performance

Gross Margin

SIBN

79.5%

BBNX

58.3%

ROE

SIBN

-823.0%

BBNX

-2630.0%

FCF Yield %

SIBN

-0.5%

BBNX

-7.7%

52-Week Performance

SIBN

27.4%

BBNX

-20.3%

Detailed metrics comparison

BBNX

Beta Bionics Inc

SIBN

SI-BONE Inc

Market Cap

BBNX$793M

SIBN$859M

Enterprise Value

BBNX$749M

SIBN$862M

Price

BBNX$17.63

SIBN$19.37

P/E Ratio

BBNXN/A

SIBNN/A

P/S Ratio

BBNX6.66x

SIBN4.02x

EV/Sales

BBNX6.29x

SIBN4.03x

EV/EBITDA

BBNX0.00x

SIBN0.00x

P/B Ratio

BBNX3.99x

SIBN4.44x

P/FCF Ratio

BBNXN/A

SIBNN/A

EV/FCF

BBNX-12.19x

SIBN-196.39x

PEG Ratio

BBNXN/A

SIBNN/A

Forward P/E (NTM)

BBNXN/A

SIBNN/A

Forward P/S (NTM)

BBNX5.37x

SIBN3.36x

Revenue (TTM)

BBNX$119M

SIBN$214M

Revenue Growth (YoY)

BBNX94.1%

SIBN15.3%

Forward Rev Growth

BBNX34.2%

SIBN15.7%

Gross Margin (TTM)

BBNX58.3%

SIBN79.5%

Operating Margin (TTM)

BBNX0.0%

SIBN0.0%

EBITDA Margin (TTM)

BBNX-67.9%

SIBN-5.3%

Net Margin (TTM)

BBNX-61.3%

SIBN-6.9%

FCF Margin (TTM)

BBNX-51.6%

SIBN-2.1%

Net Income (TTM)

BBNX$-73M

SIBN$-15M

FCF (TTM)

BBNX$-61M

SIBN$-4M

EPS (TTM)

BBNX-$1.64

SIBN-$0.33

ROE (TTM)

BBNX-2630.0%

SIBN-823.0%

ROA (TTM)

BBNX-2325.0%

SIBN-607.0%

ROIC (TTM)

BBNX-2630.0%

SIBN-686.0%

Cash

BBNX$44M

SIBN$33M

Debt

BBNX$0

SIBN$36M

Net Cash/Debt

BBNX$44M

SIBN$-3M

Current Ratio (TTM)

BBNX8.88x

SIBN9.15x

Quick Ratio (TTM)

BBNX7.72x

SIBN7.37x

Debt/Equity (TTM)

BBNX0.00x

SIBN0.20x

Debt/Assets (TTM)

BBNX0.0%

SIBN0.0%

Interest Coverage (TTM)

BBNXN/A

SIBNN/A

Net Debt/EBITDA (TTM)

BBNX0.00x

SIBN0.00x

Beta

BBNX0.92

SIBN0.65

52W Performance

BBNX-20.3%

SIBN27.4%

YTD Performance

BBNX-39.7%

SIBN-2.1%

% from 52W High

BBNX-46.1%

SIBN-11.5%

% from 52W Low

BBNX100.3%

SIBN68.7%

Asset Turnover (TTM)

BBNX0.38x

SIBN0.89x

FCF Yield (TTM)

BBNX-7.7%

SIBN-0.5%

Earnings Yield (TTM)

BBNX-9.2%

SIBN-1.7%

Dividend Yield (TTM)

BBNXN/A

SIBNN/A

Rule of 40

BBNX42.5

SIBN13.2

EV/GP/RG

BBNX0.34

SIBN0.22

Ticker research

View BBNX research View SIBN research

Metric	BBNX Beta Bionics Inc	SIBN SI-BONE Inc
Market & Valuation
Market Cap	$793M	$859M
Enterprise Value	$749M	$862M
Price	$17.63	$19.37
P/E Ratio	N/A	N/A
P/S Ratio	6.66x	4.02x
EV/Sales	6.29x	4.03x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.99x	4.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-12.19x	-196.39x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.37x	3.36x
Revenue & Growth
Revenue (TTM)	$119M	$214M
Revenue Growth (YoY)	94.1%	15.3%
Forward Rev Growth	34.2%	15.7%
Profitability
Gross Margin (TTM)	58.3%	79.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-67.9%	-5.3%
Net Margin (TTM)	-61.3%	-6.9%
FCF Margin (TTM)	-51.6%	-2.1%
Net Income (TTM)	$-73M	$-15M
FCF (TTM)	$-61M	$-4M
EPS (TTM)	-$1.64	-$0.33
ROE (TTM)	-2630.0%	-823.0%
ROA (TTM)	-2325.0%	-607.0%
ROIC (TTM)	-2630.0%	-686.0%
Financial Health
Cash	$44M	$33M
Debt	$0	$36M
Net Cash/Debt	$44M	$-3M
Current Ratio (TTM)	8.88x	9.15x
Quick Ratio (TTM)	7.72x	7.37x
Debt/Equity (TTM)	0.00x	0.20x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.92	0.65
52W Performance	-20.3%	27.4%
YTD Performance	-39.7%	-2.1%
% from 52W High	-46.1%	-11.5%
% from 52W Low	100.3%	68.7%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	0.89x
FCF Yield (TTM)	-7.7%	-0.5%
Earnings Yield (TTM)	-9.2%	-1.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	42.5	13.2
EV/GP/RG	0.34	0.22
Ticker research	View BBNX research	View SIBN research